Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4262-4266

  Buckler, Jodi L ^a   Walsh, Patrick T ^a   Porrett, Paige M ^a   Choi, Yongwon ^a   Turka, Laurence A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; INTERLEUKIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CLONAL ANERGY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; IMMUNOLOGICAL TOLERANCE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 33749132566     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4262     Document Type: Article

References (24)

1. Acuto, O., and D. Cantrell. 2000. T cell activation and the cytoskeleton. Annu. Rev. Immunol. 18: 165-184.
2. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
3. Fruman, D. A., and L. C. Cantley. 2002. Phosphoinositide 3-kinase in immunological systems. Semin. Immunol. 14: 7-18.
4. Koyasu, S. 2003. The role of PI3K in immune cells. Nat. Immunol. 4: 313-319.
5. Fruman, D. A. 2004. Phosphoinosiride 3-kinase and its targets in B cell and T cell signaling. Curr. Opin. Immunol. 16: 314-320.
6. Ward, S. G., S. C. Ley, C. MacPhee, and D. A. Cantrell. 1992. Regulation of D-3 phosphoinosirides during T cell activation via the T cell antigen receptor/CD3 complex and CD2 antigens. Eur. J. Immunol. 22: 45-49.
7. Carrera, A. C., L. Rodriguez-Borlado, C. Martinez-Alonso, and I. Merida. 1994. T cell receptor-associated α-phosphatidylinositol 3-kinase becomes activated by T cell receptor cross-linking and requires pp561ck. J. Biol. Chem. 269: 19435-19440.
8. Pages, F., M. Ragueneau, R. Rottapel, A. Truneh, J. Nunes, J. Imbert, and D. Olive. 1994. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T cell signalling. Nature 369: 327-329.
9. Ueda, Y., B. L. Levine, M. L. Huang, G. J. Freeman, L. M. Nadler, C. H. June, and S. G. Ward. 1995. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int. Immunol. 7: 957-966.
10. Kane, L. P., P. G. Andres, K. C. Howland, A. K. Abbas, and A. Weiss. 2001. Akt provides the CD28 costimulatoty signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines. Nat. Immunol 2: 37-44.
11. Cuevas, B., Y. Lu, S. Watt, R. Kumar, J. Zhang, K. A. Siminovitch, and G. B. Mills. 1999. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphotylation and activity. J. Biol. Chem. 274: 27583-27589.
12. Fang, D., and Y. C. Liu. 2001. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat. Immunol. 2: 870-875.
13. Seminario, M. C., and R. L. Wange. 2003. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial. Immunol. Rev. 192: 80-97.
14. Maehama, T., and J. E. Dixon. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273: 13375-13378.
15. Myers, M. P., I. Pass, I. H. Batty, J. Van der Kaay, J. P. Stolarov, B. A. Hemmings, M. H. Wigler, C. P. Downes, and N. K. Tonks. 1998. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA 95: 13513-13518.
16. +/- mice. Science 285: 2122-2125.
17. Suzuki, A., M. T. Yamaguchi, T. Ohteki, T. Sasaki, T. Kaisho, Y. Kimura, R. Yoshida, A. Wakeham, T. Higuchi, M. Fukumoto, et al. 2001. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14: 523-534.
18. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
19. + regulatory T cells. J. Immunol. 172: 5287-5296.
20. Jeon, M. S., A. Atfield, K. Venuprasad, C. Krawczyk, R. Sarao, C. ElIy, C. Yang, S. Arya, K. Bachmaier, L. Su, et al. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177.
21. + T cells in vivo. Transplantation 72: 1286-1292.
22. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349: 245-248.
23. Freeburn, R. W., K. L. Wright, S. J. Burgess, E. Astoul, D. A. Cantrell, and S. G. Ward. 2002. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J. Immunol. 169: 5441-5450.
24. Wells, A. D., H. Gudmundsdottir, and L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion: signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100: 3173-3183.